TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 3 | 1 | 3 | -1 | 8 | 15 | 13 | 26 | 103 | 27 |
P | %wins | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/3/21 11:10 | 12/2/21 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Classon Rolf A | MI | D | P | 100 | 35.67 | 0 | 3 | 19 | 17 | D | |||||||||||||||
11/10/20 14:18 | 11/9/20 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Classon Rolf A | MI | D | P | 100 | 46.75 | 0 | 2 | 24 | 11 | D | |||||||||||||||
11/18/08 08:00 | 11/17/08 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Classon Rolf A | NJ | D | P | 41 | 4.06 | 2 | 10 | 168 | 16 | D | -53 | -59 | -56 | -57 | -27 | -10 | -9 | 30 | -7 | 17 | 58 | 61 | 82 | 157 | |
8/15/08 09:58 | 8/11/08 | MIL | Millipore Corp /ma | MA | Electr | LabEq | Laboratory Analytical Instrum | Classon Rolf A | MA | D | P | 178 | 71.38 | 4 | 3 | 403 | 3 | D | 65 | -8 | 2 | -13 | 0 | 0 | 12 | 2 | 0 | -1 | -26 | -67 | -64 | -66 | |
11/23/05 16:14 | 11/22/05 | AUXL | Auxilium Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Classon Rolf A | PA | D | P | 25 | 5.09 | 0 | 5 | New | 5 | D | -44 | 6 | -14 | 8 | 31 | 27 | 11 | 4 | 8 | 12 | 45 | 60 | 217 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |